NEXTHERA CAPITAL LP current holdings: USA Other Stocks
NEXTHERA CAPITAL LP reported $0.07 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 26 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are Acceleron Pharma Inc, Seattle Genetics Inc, Adamas Pharmaceuticals Inc.
- Acceleron Pharma Inc: Country of operation —; Class COM; Shares 217,817; Value $7,883,000.
- Seattle Genetics Inc: Country of operation —; Class COM; Shares 111,500; Value $6,022,000.
- Adamas Pharmaceuticals Inc: Country of operation —; Class COM; Shares 278,740; Value $4,574,000.
- Aquinox Pharmaceuticals Inc: Country of operation —; Class COM; Shares 340,000; Value $4,542,000.
Form 13F-HR as filed (SEC CIK 1646343): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
| Stock | Country of operation | Class | Shares | Value | Quarter end | Filed |
|---|
Acceleron Pharma Inc
CUSIP 00434H108 | | COM | 217,817 | $7,883,000 | 2016-09-30 | 2016-11-14 |
|---|
Seattle Genetics Inc
CUSIP 812578102 | | COM | 111,500 | $6,022,000 | 2016-09-30 | 2016-11-14 |
|---|
Adamas Pharmaceuticals Inc
CUSIP 00548A106 | | COM | 278,740 | $4,574,000 | 2016-09-30 | 2016-11-14 |
|---|
Aquinox Pharmaceuticals Inc
CUSIP 03842B101 | | COM | 340,000 | $4,542,000 | 2016-09-30 | 2016-11-14 |
|---|
Lannett Co Inc
CUSIP 516012101 | | COM | 167,000 | $4,437,000 | 2016-09-30 | 2016-11-14 |
|---|
Clovis Oncology Inc
CUSIP 189464100 | | COM | 120,000 | $4,326,000 | 2016-09-30 | 2016-11-14 |
|---|
Immunomedics Inc
CUSIP 452907108 | | COM | 1,263,276 | $4,106,000 | 2016-09-30 | 2016-11-14 |
|---|
CoLucid Pharmaceuticals Inc
CUSIP 19716T101 | | COM | 100,000 | $3,815,000 | 2016-09-30 | 2016-11-14 |
|---|
Eiger BioPharmaceuticals Inc
CUSIP 28249U105 | | COM | 264,000 | $3,535,000 | 2016-09-30 | 2016-11-14 |
|---|
Zogenix Inc
CUSIP 98978L204 | | COM NEW | 260,000 | $2,972,000 | 2016-09-30 | 2016-11-14 |
|---|
FibroGen Inc
CUSIP 31572Q808 | United States | COM | 127,680 | $2,643,000 | 2016-09-30 | 2016-11-14 |
|---|
Neuroderm Ltd
CUSIP M74231107 | | ORD SHS | 131,000 | $2,422,000 | 2016-09-30 | 2016-11-14 |
|---|
Immune Design Corp
CUSIP 45252L103 | | COM | 305,000 | $2,312,000 | 2016-09-30 | 2016-11-14 |
|---|
Progenics Pharmaceuticals Inc
CUSIP 743187106 | | COM | 350,000 | $2,216,000 | 2016-09-30 | 2016-11-14 |
|---|
Advaxis Inc
CUSIP 007624208 | | COM NEW | 200,000 | $2,138,000 | 2016-09-30 | 2016-11-14 |
|---|
Trevena Inc
CUSIP 89532E109 | | COM | 298,849 | $2,017,000 | 2016-09-30 | 2016-11-14 |
|---|
Abeona Therapeutics Inc
CUSIP 00289Y107 | | COM | 321,609 | $1,930,000 | 2016-09-30 | 2016-11-14 |
|---|
Aerie Pharmaceuticals Inc
CUSIP 00771V108 | | COM | 50,000 | $1,887,000 | 2016-09-30 | 2016-11-14 |
|---|
Concert Pharmaceuticals Inc
CUSIP 206022105 | | COM | 167,866 | $1,697,000 | 2016-09-30 | 2016-11-14 |
|---|
Axovant Sciences Ltd
CUSIP G0750W104 | | COM | 100,000 | $1,400,000 | 2016-09-30 | 2016-11-14 |
|---|
Foamix Pharmaceuticals Ltd
CUSIP M46135105 | | SHS | 125,000 | $1,158,000 | 2016-09-30 | 2016-11-14 |
|---|
Ophthotech Corp
CUSIP 683745103 | | COM | 24,000 | $1,107,000 | 2016-09-30 | 2016-11-14 |
|---|
VistaGen Therapeutics Inc
CUSIP 92840H202 | | COM NEW | 138,132 | $575,000 | 2016-09-30 | 2016-11-14 |
|---|
Verastem Inc
CUSIP 92337C104 | | COM | 336,000 | $447,000 | 2016-09-30 | 2016-11-14 |
|---|
Vascular Biogenics Ltd
CUSIP M96883109 | | COM | 33,332 | $174,000 | 2016-09-30 | 2016-11-14 |
|---|
BioPharmX Corp
CUSIP 09072X101 | | COM | 57,656 | $32,000 | 2016-09-30 | 2016-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |